HBIOHarvard Bioscience, Inc.$ --
Harvard Bioscience, Inc.
HBIO
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
wallet
Earnings SummaryUpdated: 03/31/2026FY2026 Q1
Revenue
21M USD
YoY -4.7%
Operating Income
-0M USD
YoY +99.8%
Net Income
-3M USD
YoY +93.2%
EPS
-0.77$
YoY +93.2%
Revenue
$20.8M
Actual
$-1M (-4.7%)
Net Income
$-3.4M
Actual
+$46.9M (+93.2%)
Surprise History
Actual RevenueAnalyst Estimate
FY2020IN-LINE
Actual:$102.1M
Est:$102.1M
FY2020IN-LINE
FY2021BEAT
Actual:$118.9M
Est:$118.3M
FY2021BEAT
FY2022MISS
Actual:$113.3M
Est:$115.2M
FY2022MISS
FY2023BEAT
Actual:$112.3M
Est:$101.1M
FY2023BEAT
FY2024BEAT
Actual:$94.1M
Est:$93.8M
FY2024BEAT
FY2025BEAT
Actual:$86.5M
Est:$85.9M
FY2025BEAT